HROW Price Targets and Analyst Ratings NASDAQ:HROW
HROW Forecast. What You Should Know.
HROW Historical Ratings and Targets
About Imprimis Pharmaceuticals
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharma... HROW Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.